Related Experiment Video
Updated: Apr 6, 2026

13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
10.5K
Mumps in Poland in 2013
Monika Roberta Korczyńska1, Justyna Rogalska1
1Department of Epidemiology, National Institute of Public Health - National Institute of Hygiene in Warsaw.
Przeglad Epidemiologiczny
|August 3, 2015
Summary
Mandatory mumps vaccination in Poland has significantly reduced cases, with high coverage expected to further decrease incidence. This study assesses the 2013 epidemiological situation and vaccination rates.
Area of Science:
- Epidemiology
- Public Health
- Immunization
Background:
- Mumps vaccination has been mandatory in Poland since 2003, utilizing a two-dose MMR vaccine schedule.
- Despite a decade-long decline in incidence due to vaccination efforts, mumps remains a prevalent childhood illness.
Purpose of the Study:
- To evaluate the 2013 epidemiological status of mumps in Poland.
- To assess vaccination coverage within the Polish population and compare it to previous years.
Main Methods:
- Descriptive analysis of mandatory surveillance data from "Infectious diseases and poisonings in Poland in 2013" and "Vaccinations in Poland in 2013".
- Mumps case classification adhered to European Union surveillance criteria.
- Analysis incorporated the National Immunisation Programme for 2013.
Main Results:
- Poland registered 2,436 mumps cases in 2013, with an incidence rate of 6.3 per 100,000, a decrease from 2012 and the 2007-2010 median.
- The highest incidence was observed in 5-year-old children (54.0 per 100,000); incidence was higher in males (7.5) than females (5.2).
- Vaccination coverage for 3-year-olds was 97.5%, a slight decrease from 2012; 38 hospitalizations occurred.
Conclusions:
- Consistent implementation of the National Immunisation Programme has led to a substantial reduction in reported mumps cases.
- High vaccination coverage suggests an anticipated further decrease in mumps incidence.
Related Concept Videos
Infectious Diseases and Their Occurrence
58
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
58
Vaccinations
54.0K
Overview
54.0K
Atypical Pneumonia
47
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
47
Viral Meningitis
115
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
115
Influenza
43
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
43

